Signet Showcases Expanded Pharma, Biopharma, and Medical Device Portfolio at CPhI India 2025

Signet successfully concluded their presence at CPhI India, drawing strong engagement from innovators, formulators, and industry leaders. We unveiled our expanded portfolio, now spanning pharmaceutical excipients, advanced biopharma process solutions, and a growing range of medical device offerings. The booth was inaugurated by Narendra Varde, Palak Vij, Geena Malhotra, Wilson D’Souza, Dr. Heeshma Shah and Dr. Sagar Mahajan, setting the stage for dynamic discussions throughout the event.

Visitors explored how high-quality excipients continue to enhance formulation performance, stability, scalability, and sustainability—key priorities for India’s rapidly evolving pharma landscape. The upgraded list of pharmaceutical excipients assured extended support for addressing current regulatory queries.

Biopharma solutions drew significant interest to support India’s ambitions in high-value biologics. The newly introduced medical device segment was also well received, reinforcing Signet’s commitment to providing an integrated, one-stop platform for regulated and future-ready products.

Across three days, the event fostered meaningful dialogue, fresh perspectives, and collaborative opportunities that will help accelerate progress in pharmaceutical and biopharmaceutical industry. Signet expressed appreciation to all visitors whose insights and curiosity made this CPhI both impactful and forward-looking.